A Note on AI for Medicine and Biotech
Suppose that frontier AI development is centralized to a single project under tight international controls, with all other development banned internationally. By far the likeliest outcome of this is that we all die. A centralized group of international researchers — a “CERN for AI” — can’t align superintelligence any more than decentralized organizations can. Centralization […] The post A Note on AI for Medicine and Biotech appeared first on Machine Intelligence Research Institute.
Why it matters
This article highlights the challenges and risks of centralized governance of transformative AI systems, especially in critical areas like healthcare and biotechnology.
Key Points
- 1Centralized AI development for medicine and biotech is unlikely to be successfully aligned
- 2A
- 3 cannot reliably align superintelligence any better than decentralized organizations
- 4Tight international controls on AI development in these critical domains could lead to catastrophic outcomes
Details
The article suggests that concentrating frontier AI development for medicine and biotechnology under a single, tightly controlled international project would be extremely risky. The author argues that even a centralized group of top researchers, akin to a
No comments yet
Be the first to comment